GvHD Induction using Immuno-Deficient Mouse Models engrafted with human PBMCs

TransCure bioServices priority is the health of all our collaborators and the well-being of the animals under our supervision while also ensuring the continuity of our customer’s projects. At this point:

• No impact on the execution of the signed/ongoing Studies
• No delay for the novel Studies Initiation  

Implementation of COVID-19 Measures to reduce its impact on our Services

Our Executive Leadership Team is e-meeting frequently in order to evaluate the global and local situations and to ensure that we provide resources and information to manage the situation as effectively as possible. Here are some actions that TransCure bioServices are taking in order to mitigate the effects on our services and business to our customers:

• Communicating internally the importance of fundamental personal hygiene practices (i.e. hand washing, coughing, etc.).
• Sick policies and remote work opportunities are being considered where applicable.
• Non-essential travel has been strictly limited to local meetings and small group events.
• Plan to ensure the business continuity in case of any employee absenteeism

For any questions or concerns, please contact us.